Cross Country Healthcare (CCRN) Sets Q4 2025 Earnings Call Date
CROSS COUNTRY HEALTHCARE INC
Subscribe to track CCRN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Cross Country Healthcare (CCRN) Sets Q4 2025 Earnings Call Date
Company: Cross Country Healthcare, Inc. (CCRN) Form: 8-K | Filed: 2026-02-12 Significance: Low
Key Insight: The company filed a Form 8-K to announce its fourth quarter and full year 2025 earnings conference call, scheduled for Wednesday, March 4, 2026.
Market Context: This is a routine, administrative filing to disclose the timing of a future, scheduled event. It contains no new material financial information and is not expected to have an immediate impact on the stock.
Comprehensive Analysis
SEC Filing Analysis: Cross Country Healthcare, Inc. (CCRN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Cross Country Healthcare has scheduled its Q4 and full-year 2025 earnings conference call for March 4, 2026.
- Market Impact: Neutral. This is a standard administrative announcement with no new financial data.
Company Information
| Field | Value |
|---|---|
| Company | CROSS COUNTRY HEALTHCARE INC |
| Ticker Symbol | CCRN |
| CIK | 0001141103 |
| Industry | Services-Help Supply Services |
Filing Details
| Field | Value |
|---|---|
| Form Type | 8-K |
| Filing Date | 2026-02-12 |
| Period of Report | 2026-02-12 |
| Items | 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits) |
Analysis
This Form 8-K serves as a public announcement for Cross Country Healthcare's upcoming earnings conference call. The filing, made under Regulation FD, ensures fair disclosure of the event's timing.
Market Impact Assessment
- Direction: Neutral
- Reasoning: The filing is purely informational and procedural. It does not contain any performance metrics, guidance, or unexpected material information. Announcing an earnings call is a routine part of a public company's investor relations cycle.
- Expected Volume Impact: Negligible. There is no information in this filing that would typically drive trading volume.
- Sentiment Indicator: Neutral. The filing confirms the company is following its standard reporting schedule.
Key Takeaways
- Routine Disclosure: This is a standard administrative filing with no investment thesis implications.
- Event Scheduling: Investors and analysts can mark their calendars for the earnings release and call on March 4, 2026.
- No Transaction: The filing does not report any insider trades, financing, or other material financial events.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.